CLINICAL_TRIALS ClinicalTrials.gov record update

Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01096368
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:29:01.090726+00:00
Published At: 2023-03-02T00:00:00+00:00
Record Updated At: 2025-10-27
Results Posted At: 2023-03-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Anaplastic Ependymoma", "Brain Ependymoma", "Cellular Ependymoma", "Clear Cell Ependymoma", "Ependymoma", "Papillary Ependymoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-10-27"
protocolSection.identificationModule.nctId: "NCT01096368"
protocolSection.identificationModule.officialTitle: "Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2023-03-02"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.